Cite

    Lee S Schwartzberg et al.. “Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial.” Lancet oncology, vol. 16, no. 9, n.d., pp. 1071–1078. http://access.bl.uk/ark:/81055/vdc_100051218329.0x000022